focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Phorm Announces Board Changes

1 Dec 2008 07:00

RNS Number : 2435J
Phorm Inc
01 December 2008
 

Phorm, Inc. ("Phorm" or the "Company")

Phorm Announces Board Changes 

Phorm (AIM: PHRM and PHRX), the advertising technology company, announces the following changes to the Company's Board:

Norman Lamont is appointed to the Board as a Non-Executive Director. Mr. Lamont was a Cabinet Minister under both Margaret Thatcher and John Major, served as Chancellor of the Exchequer from 1990 to 1993 and was a member of the House of Commons for twenty-five years.

Kip Meek, currently Chairman of the Broadband Stakeholders Group and of Ingenious Consulting Network, joins the Board as a Non-Executive Director. From 2003 until 2007, he was an Executive Board member of Ofcom. Mr. Meek was previously Managing Director of Spectrum Strategy Consultants and Partner at Coopers & Lybrand, where he led the Media and Telecoms practice.

Stefan Allesch-Taylor, Chief Executive of Fairfax, an international, independent investment bank, is appointed a Non-Executive Director on the Board. As one of the founders of Fairfax, he has a strong business background and considerable AIM market experience.

Stephen Partridge-Hicks is appointed to the Board as a Non-Executive Director. Mr. Partridge-Hicks is the co-founder and Managing Director of Gordian Knot, an FSA regulated investment management company registered in England. Prior to establishing Gordian Knot and Sigma Finance Corporation, a $57 billion investment fund, he worked at Citibank in London. He has extensive knowledge and experience within the financial sector in the UK.

Steven Heyer, David Dorman, Christopher Lawrence and Virasb Vahidi will step down from the Board with immediate effect. Virasb Vahidi, Chief Operating Officer, will also leave the Company with immediate effect.

Messrs. Heyer, Dorman, Lawrence and Vahidi will take this action as a result of differences with Mr. Ertugrul as to the management and future direction of the Company.

Kent Ertugrul, CEO of Phorm, commented: "I would like to thank Steve, Dave, Chris and Virasb for the important contributions they have made to Phorm's development.  Their skills, experience and contacts have been immensely valuable and have been instrumental in the great strides we have made in developing the Company's strategy and building relationships with ISPs, advertisers and publishers.

"Meanwhile, I welcome Lord Lamont, Kip, Stefan and Stephen to the Board. They bring extensive experience on government, business, regulatory matters and financial markets. As we move into the next phase of our development, the priority will be to build momentum in the rollout of our strategy. The new Board members that we are announcing today will play an important role in helping us to achieve the Company's goals."

Save as set out in the Appendix, there are no further details in relation to the above appointments which require disclosure under paragraph (g) of Schedule 2 to the AIM Rules.

NOTES TO EDITORS:

For Phorm Enquiries: 

Investor Relations +44 (0) 207 297 2067

Brunswick Group

Craig Breheny +44 (0) 20 7404 5959Azhar Khan

Citigate Dewe Rogerson +44 (0) 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited +44 (0) 20 7050 6500 

(Nominated Adviser) 

Mark Williams 

Andrew Chubb 

About Phorm: 

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users' personal privacy and security.

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware corporation with offices in New YorkLondon and Moscow. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com.

Appendix

Information provided in accordance with paragraph g of Schedule 2 to the AIM rules:

1. Details of full name, age, previous names:

Full Name: Stefan Paul Allesch-Taylor

Age: 39

 

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner

Powderblue Pictures Ltd present 

Fairfax I.S. PLC (formerly Fairfax I.S. management Ltd) - present 

Fairfax Group Ltd present 

Fairfax Capital Ltd present 

Tactica Fund PCC PLC present 

Tactica Fund Management Ltd present 

Fairfax Investment Management Limited - present 

Develica Management Ltd - Resigned: 30/06/05 

Accsys Technologies PLC - Resigned: 09/05/07

Savoy Asset Management Ltd - Resigned: 10/04/06 

Library of Life (Europe) Ltd - Resigned: 28/01/04

Tactica Advisory (UK) Ltd - Resigned: 17/09/08 

*Medicsight Inc - Resigned: 08/12/03

1. Details of full name, age, previous names

Full Name: Richard Stephen Partridge-Hicks ("Stephen Partridge-Hicks")

Age: 51

Previous name: Richard Stephen Hicks

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner:

Gordian Knot Limited

Sigma Finance Corporation

1. Details of full name, age, previous names

Full Name: Norman Stewart Hughson Lamont (The Right Hon. Lord Lamont of Lerwick)

Age: 66

2. Names of all companies and partnerships of which the director has been a director or partner at any time in the previous five years, indicating whether or not the director is still a director or partner:

Balli Group plc - present

Compagnie internationale de participations bancaires et financiers SA (CIPAF) - present

RAB Capital plc - present

Jupiter Second Split - present

Jupiter Adria - present

Small Companies Dividend Trust PLC - present

Pantin Hotels Management Ltd - present

Jupiter Off-shore Portfolio Fund Limited - present

Union Resources Limited - present

Banca Commerciala RobankRomania - Resigned: 2005

European Growth & Income Trust - Resigned: 2005

Jupiter Finance and Income Trust - Resigned: 2005

East European Food Fund - Resigned: 2005

Galileo plc - Resigned: 2005

Scottish Re Group Limited - Resigned: 2007

1. Details of full name, age, previous names

Full Name: Kingsley John Neville Meek ("Kip")

Age: 53

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWUGMGGUPRPPU
Date   Source Headline
26th Mar 20145:00 pmRNSIntention to raise £10 million
10th Mar 20147:01 amRNSMemorandum of Understanding with China Telecom
27th Jan 20147:00 amRNSCommercial Launch in China
20th Jan 20147:00 amRNSChange of Adviser
17th Jan 20147:00 amRNSAIM Rule 17 Disclosure Schedule Two (g) Update
6th Jan 20147:00 amRNSExercise of Employee Warrants for Shares
19th Nov 20137:00 amRNSOperational Update for Phorm China
19th Nov 20137:00 amRNSEquity Placing to raise £10 million
13th Nov 20137:12 amRNSStmnt re Share Price Movement
24th Oct 201311:16 amRNSOperations Update
3rd Oct 20137:00 amRNSOperational Launch in China
30th Sep 20137:00 amRNSInterim Results
27th Sep 20137:00 amRNSOperations Update
28th Aug 201312:43 pmRNSAGM Statement
7th Aug 201310:52 amRNSStmnt re Share Price Movement
6th Aug 20137:00 amRNSAGM Statement
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
26th Jul 20137:00 amRNSTR1: Notification of major interest in shares
17th Jul 20139:20 amRNSIssue of Equity
28th Jun 20137:20 amRNSAnnual Report and Financial Statements
28th Jun 20137:20 amRNSTurkish Operations Update
29th May 20137:00 amRNSFinancing Update
8th May 20138:34 amRNSHolding(s) in Company
23rd Apr 201310:18 amRNSPlacing to raise £7.15 million
21st Mar 20133:20 pmRNSStatement re Share Price Movement
20th Mar 20137:00 amRNSFinancing Update
24th Jan 20137:00 amRNSChinese and Turkish Operations Update
4th Jan 20137:00 amRNSIssue of Shares
18th Dec 20127:00 amRNSIssue of Shares
17th Dec 20127:00 amRNSTurkish Operational Update
13th Dec 20127:00 amRNSTR1: Notification of major interest in shares
21st Nov 201212:33 pmRNSResult of EGM & Admission to trading
6th Nov 201211:50 amRNS£6m Placing, Contract Signature & Turkey Update
16th Oct 20127:00 amRNSCommercial Progress Update
28th Sep 20127:00 amRNSInterim Results
20th Sep 20127:00 amRNSUpdate on Turkey and Phorm China Equity Fundraise
11th Sep 20127:00 amRNSAdmission to Trading
10th Sep 20123:33 pmRNSSch 1 Update - Phorm Corporation Limited
7th Sep 20122:58 pmRNSResults of EGM - Correction
7th Sep 201212:29 pmRNSResults of EGM
5th Sep 20124:15 pmRNSNotification of Major Interests in Shares
31st Aug 20123:49 pmRNSUpdated Appendix to Schedule 1
13th Aug 20129:06 amRNSSchedule 1 - Phorm Corporation Limited
13th Aug 20127:00 amRNSPhorm Re-Domicile of Holding Company from Delaware
2nd Aug 20127:00 amRNSPlacing
9th Jul 20127:00 amRNSCommencement of Commercial Activities with TTNET
3rd Jul 201210:14 amRNSTransfer of Shares
29th Jun 20127:00 amRNSAnnual Financial Report
19th Jun 20126:01 pmRNSCorrection: AGM Result
19th Jun 201211:29 amRNSAGM Result

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.